iBet uBet web content aggregator. Adding the entire web to your favor.
iBet uBet web content aggregator. Adding the entire web to your favor.



Link to original content: http://fr.statista.com/statistics/1239542/pre-commercial-biopharma-pipeline-cagr-by-therapeutic/
Biopharma pipeline CAGR by type worldwide 2010-2020 | Statista

CAGR of pre-commercial biopharma pipeline by therapeutic worldwide 2010-2020

Published by
Matej Mikulic,
May 28, 2021
For the period 2010-2020, the compound annual growth rate of mRNA based therapeutics worldwide was 47 percent. This statistic illustrates the compound annual growth rate of the pre-commercial biopharma pipeline between 2010 and 2020, by type of therapeutic.

CAGR of pre-commercial biopharma pipeline worldwide for the period 2010-2020, by therapeutic

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Use Ask Statista Research Service

Release date

April 2021

Region

Worldwide

Survey time period

2010 to 2020

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Pharma and biotech M&A activity "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Pharma and biotech M&A activity

Industry overview

5

Number of deals

7

Value of deals

5

Mega-merger: BMS/Celgene

5

2021 outlook

4

Further related statistics

10

Further Content: You might find this interesting as well

Statistics

Topics

Coronavirus (COVID-19) in JapanPharmaceutical industry in JapanTravel and tourism industry in JapanHealth care in JapanHospitals in Japan
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.